| Miss Mary Alice Ryman, OTRL CHT | |
|
100 E Carroll St, Salisbury, MD 21801-5422 | |
| (410) 543-7069 | |
| (410) 543-4753 |
| Full Name | Miss Mary Alice Ryman |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 29 Years |
| Location | 100 E Carroll St, Salisbury, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225252000 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XH1200X | Occupational Therapist - Hand | 04429 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peninsula Orthopaedic Assoc., Pa | 6406844406 | 41 |
News Archive
The National Eye Institute on Thursday said it will finance a two-year study comparing the effectiveness of Genentech's eye treatment Lucentis and cancer drug Avastin for treating wet age-related macular degeneration, the New York Times reports.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC) at the Cancer Hospital of Chinese Academy of Medical Sciences in Beijing, China.
Cold sensing neural circuits in newborn mice take around two weeks to become fully active, according to a new study. The finding adds to understanding of the cold sensing protein TRPM8 (pronounced trip-em-ate), first identified in a Nature paper in 2002 by David McKemy of the University of Southern California.
The Episcopal Diocese of Texas today transferred St. Luke's Episcopal Health System to Catholic Health Initiatives, the nation's third-largest faith-based health system, officials announced.
Results of a large-scale clinical trial presented today at the annual meeting of the Radiological Society of North America (RSNA) provide the first strong evidence of the benefit of annual screening ultrasound for women with dense breasts who are at elevated risk for breast cancer. In addition, the study confirmed that MRI is highly sensitive in depicting early breast cancer.
› Verified 4 days ago
| Provider Name | Peninsula Orthopaedic Assoc., Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1811188766 PECOS PAC ID: 6406844406 Enrollment ID: O20040505001828 |
News Archive
The National Eye Institute on Thursday said it will finance a two-year study comparing the effectiveness of Genentech's eye treatment Lucentis and cancer drug Avastin for treating wet age-related macular degeneration, the New York Times reports.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC) at the Cancer Hospital of Chinese Academy of Medical Sciences in Beijing, China.
Cold sensing neural circuits in newborn mice take around two weeks to become fully active, according to a new study. The finding adds to understanding of the cold sensing protein TRPM8 (pronounced trip-em-ate), first identified in a Nature paper in 2002 by David McKemy of the University of Southern California.
The Episcopal Diocese of Texas today transferred St. Luke's Episcopal Health System to Catholic Health Initiatives, the nation's third-largest faith-based health system, officials announced.
Results of a large-scale clinical trial presented today at the annual meeting of the Radiological Society of North America (RSNA) provide the first strong evidence of the benefit of annual screening ultrasound for women with dense breasts who are at elevated risk for breast cancer. In addition, the study confirmed that MRI is highly sensitive in depicting early breast cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Mary Alice Ryman, OTRL CHT 26978 Hamden Dr, Salisbury, MD 21801-1754 Ph: (410) 677-4969 | Miss Mary Alice Ryman, OTRL CHT 100 E Carroll St, Salisbury, MD 21801-5422 Ph: (410) 543-7069 |
News Archive
The National Eye Institute on Thursday said it will finance a two-year study comparing the effectiveness of Genentech's eye treatment Lucentis and cancer drug Avastin for treating wet age-related macular degeneration, the New York Times reports.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC) at the Cancer Hospital of Chinese Academy of Medical Sciences in Beijing, China.
Cold sensing neural circuits in newborn mice take around two weeks to become fully active, according to a new study. The finding adds to understanding of the cold sensing protein TRPM8 (pronounced trip-em-ate), first identified in a Nature paper in 2002 by David McKemy of the University of Southern California.
The Episcopal Diocese of Texas today transferred St. Luke's Episcopal Health System to Catholic Health Initiatives, the nation's third-largest faith-based health system, officials announced.
Results of a large-scale clinical trial presented today at the annual meeting of the Radiological Society of North America (RSNA) provide the first strong evidence of the benefit of annual screening ultrasound for women with dense breasts who are at elevated risk for breast cancer. In addition, the study confirmed that MRI is highly sensitive in depicting early breast cancer.
› Verified 4 days ago
Alexis T Bloxom, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-546-6400 | |
Denise Willemin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 27751 Nanticoke Rd, Salisbury, MD 21801 Phone: 816-799-1862 | |
Caitlin Barry, OT R/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-546-6400 Fax: 410-543-7410 | |
Katie Parker, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2424 Northgate Dr Ste 100, Salisbury, MD 21801 Phone: 410-677-4400 | |
Konlian,o'neill & Associates, P.a. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 659 S Salisbury Blvd Ste 1b, Salisbury, MD 21801 Phone: 410-677-0700 Fax: 410-677-0883 | |
Bridget Kathleen Kleinhanz, MS, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 105 Time Sq, Salisbury, MD 21801 Phone: 410-749-2474 | |
Kylie Nicholson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1336 Belmont Ave Ste 502, Salisbury, MD 21804 Phone: 410-546-2894 |